This inventor holds 1 USPTO granted patent. Top assignee: Ludwig Institute for Cancer Research Limited. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: The Innovations of Pontus Aspenstrom
Introduction
Pontus Aspenstrom is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid research. His work has implications for cancer research and therapeutic development.
Latest Patents
Pontus Aspenstrom holds a patent for "Isolated nucleic acid molecules encoding PARG, a GTPase activating." This invention describes nucleic acids that encode the PARG protein, including fragments and biologically functional variants. The patent also includes polypeptides and fragments encoded by such nucleic acids, along with antibodies related to them. Furthermore, methods and products for utilizing these nucleic acids and polypeptides are provided.
Career Highlights
Aspenstrom is affiliated with the Ludwig Institute for Cancer Research Limited, where he continues to advance his research. His work focuses on understanding the molecular mechanisms underlying cancer, which is crucial for developing new therapeutic strategies.
Collaborations
Pontus collaborates with esteemed colleagues such as Jan Saras and Petra Franzen. Their combined expertise enhances the research efforts at the Ludwig Institute for Cancer Research Limited.
Conclusion
Pontus Aspenstrom's innovative work in nucleic acid research exemplifies the critical role of inventors in advancing scientific knowledge and therapeutic applications. His contributions are vital to the ongoing fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile